OVERLOOKED

Recalls › Medicines & devices

Class IIOngoing

ONESOURCE SPECIALTY PHARMA LIMITED recalls Methohexital Sodium for Injection

Recall date · record updated Jul 15, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)

What to do

Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.

Company
ONESOURCE SPECIALTY PHARMA LIMITED
Reason
Failed Impurities/Degradation Specifications
Hazard
FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
Who’s affected
Nationwide within the United States
Where
Nationwide
Official notice
www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99220…

Products

  1. Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

    Codes/lots: Lot #: 7000612A, Exp. Date 1/2028Quantity: 4284 vialsRecall no. D-0662-2026Class II

Update history

  1. First listed on OVERLOOKED from the official record.

When the agency expands or changes this recall, we update this page and log the change here.

Proof: raw official record (JSON) · fetched from FDA API

More Medicines & devices recalls